234 related articles for article (PubMed ID: 23879812)
1. Reduction of inflammatory slan (6-sulfo LacNAc) dendritic cells in psoriatic skin of patients treated with etanercept.
Günther C; Blau K; Förster U; Viehweg A; Wozel G; Schäkel K
Exp Dermatol; 2013 Aug; 22(8):535-40. PubMed ID: 23879812
[TBL] [Abstract][Full Text] [Related]
2. Human 6-sulfo LacNAc (slan) dendritic cells have molecular and functional features of an important pro-inflammatory cell type in lupus erythematosus.
Hänsel A; Günther C; Baran W; Bidier M; Lorenz HM; Schmitz M; Bachmann M; Döbel T; Enk AH; Schäkel K
J Autoimmun; 2013 Feb; 40():1-8. PubMed ID: 22890025
[TBL] [Abstract][Full Text] [Related]
3. Infliximab induces downregulation of the IL-12/IL-23 axis in 6-sulfo-LacNac (slan)+ dendritic cells and macrophages.
Brunner PM; Koszik F; Reininger B; Kalb ML; Bauer W; Stingl G
J Allergy Clin Immunol; 2013 Nov; 132(5):1184-1193.e8. PubMed ID: 23890755
[TBL] [Abstract][Full Text] [Related]
4. The phosphodiesterase 4 inhibitor apremilast inhibits Th1 but promotes Th17 responses induced by 6-sulfo LacNAc (slan) dendritic cells.
Oehrl S; Prakash H; Ebling A; Trenkler N; Wölbing P; Kunze A; Döbel T; Schmitz M; Enk A; Schäkel K
J Dermatol Sci; 2017 Aug; 87(2):110-115. PubMed ID: 28499587
[TBL] [Abstract][Full Text] [Related]
5. Human 6-sulfo LacNAc (slan) dendritic cells are a major population of dermal dendritic cells in steady state and inflammation.
Günther C; Starke J; Zimmermann N; Schäkel K
Clin Exp Dermatol; 2012 Mar; 37(2):169-76. PubMed ID: 22188261
[TBL] [Abstract][Full Text] [Related]
6. Controlling the pro-inflammatory function of 6-sulfo LacNAc (slan) dendritic cells with dimethylfumarate.
Oehrl S; Olaru F; Kunze A; Maas M; Pezer S; Schmitz M; Schäkel K
J Dermatol Sci; 2017 Sep; 87(3):278-284. PubMed ID: 28732748
[TBL] [Abstract][Full Text] [Related]
7. Etanercept suppresses regenerative hyperplasia in psoriasis by acutely downregulating epidermal expression of interleukin (IL)-19, IL-20 and IL-24.
Wang F; Smith N; Maier L; Xia W; Hammerberg C; Chubb H; Chen C; Riblett M; Johnston A; Gudjonsson JE; Helfrich Y; Kang S; Fisher GJ; Voorhees JJ
Br J Dermatol; 2012 Jul; 167(1):92-102. PubMed ID: 22458549
[TBL] [Abstract][Full Text] [Related]
8. Etanercept induces apoptosis of dermal dendritic cells in psoriatic plaques of responding patients.
Malaviya R; Sun Y; Tan JK; Wang A; Magliocco M; Yao M; Krueger JG; Gottlieb AB
J Am Acad Dermatol; 2006 Oct; 55(4):590-7. PubMed ID: 17010737
[TBL] [Abstract][Full Text] [Related]
9. Reciprocal activating interaction between 6-sulfo LacNAc+ dendritic cells and NK cells.
Wehner R; Löbel B; Bornhäuser M; Schäkel K; Cartellieri M; Bachmann M; Rieber EP; Schmitz M
Int J Cancer; 2009 Jan; 124(2):358-66. PubMed ID: 18942710
[TBL] [Abstract][Full Text] [Related]
10. [The role of human 6-sulfo LacNAc dendritic cells (slanDCs) in autoimmunity and tumor diseases].
Döbel T; Schäkel K
J Dtsch Dermatol Ges; 2014 Oct; 12(10):874-80. PubMed ID: 25262889
[TBL] [Abstract][Full Text] [Related]
11. TNFalpha and its receptors in psoriatic skin, before and after treatment with etanercept.
Caldarola G; De Simone C; Carbone A; Tulli A; Amerio P; Feliciani C
Int J Immunopathol Pharmacol; 2009; 22(4):961-6. PubMed ID: 20074459
[TBL] [Abstract][Full Text] [Related]
12. Etanercept for psoriasis: two case reports.
Fidalgo A; Baptista J; Rocha Páris F; Caldas Lopes L; Ferreira A
Int J Clin Pharmacol Res; 2005; 25(4):159-63. PubMed ID: 16402631
[TBL] [Abstract][Full Text] [Related]
13. TNFR2 and IL-12 coactivation enables slanDCs to support NK-cell function via membrane-bound TNF-α.
Tufa DM; Chatterjee D; Low HZ; Schmidt RE; Jacobs R
Eur J Immunol; 2014 Dec; 44(12):3717-28. PubMed ID: 25229755
[TBL] [Abstract][Full Text] [Related]
14. Pollen-derived low-molecular weight factors inhibit 6-sulfo LacNAc+ dendritic cells' capacity to induce T-helper type 1 responses.
Gilles S; Jacoby D; Blume C; Mueller MJ; Jakob T; Behrendt H; Schaekel K; Traidl-Hoffmann C
Clin Exp Allergy; 2010 Feb; 40(2):269-78. PubMed ID: 20210806
[TBL] [Abstract][Full Text] [Related]
15. Reconstitution of 6-sulfo LacNAc dendritic cells after allogeneic stem-cell transplantation.
Mager K; Wehner R; Bahr F; Oelschlägel U; Platzbecker U; Wermke M; Shayegi N; Middeke JM; Radke J; Röllig C; Schetelig J; Thiede C; Ehninger G; Schmitz M; Bornhäuser M; Tuve S
Transplantation; 2012 Jun; 93(12):1270-5. PubMed ID: 22643330
[TBL] [Abstract][Full Text] [Related]
16. Effects of etanercept on urine neopterin levels in patients with psoriasis in a controlled, open-label study.
Koc E; Tunca M; Akgul EO; Akar A; Kurt Y; Kurumlu Z; Erbil K; Kilic S
J Dermatol; 2009 Apr; 36(4):191-6. PubMed ID: 19348656
[TBL] [Abstract][Full Text] [Related]
17. Th1, Th2, Th17 and regulatory T cell pattern in psoriatic patients: modulation of cytokines and gene targets induced by etanercept treatment and correlation with clinical response.
Quaglino P; Bergallo M; Ponti R; Barberio E; Cicchelli S; Buffa E; Comessatti A; Costa C; Terlizzi ME; Astegiano S; Novelli M; Cavallo R; Bernengo MG
Dermatology; 2011; 223(1):57-67. PubMed ID: 21865674
[TBL] [Abstract][Full Text] [Related]
18. Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes.
Zaba LC; Suárez-Fariñas M; Fuentes-Duculan J; Nograles KE; Guttman-Yassky E; Cardinale I; Lowes MA; Krueger JG
J Allergy Clin Immunol; 2009 Nov; 124(5):1022-10.e1-395. PubMed ID: 19895991
[TBL] [Abstract][Full Text] [Related]
19. Extracorporeal photopheresis efficiently impairs the proinflammatory capacity of human 6-sulfo LacNAc dendritic cells.
Gerner M; Hölig K; Wehner R; Zhao S; Schäkel K; Bachmann MP; Rieber EP; Bornhäuser M; Schmitz M
Transplantation; 2009 Apr; 87(8):1134-9. PubMed ID: 19384158
[TBL] [Abstract][Full Text] [Related]
20. Etanercept, a TNF antagonist for treatment for psoriatic arthritis and psoriasis.
Mease PJ
Skin Therapy Lett; 2003 Jan; 8(1):1-4. PubMed ID: 12728284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]